This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tesfaye, A. Articles by Resar, L. M. S. Search for Related Content PubMed PubMed Citation Articles by Tesfaye, A. Articles by Resar, L. M. S.

The High-Mobility Group A1 Gene Up-Regulates Cyclooxygenase 2 Expression in Uterine Tumorigenesis

¹ Hematology Division, Departments of ² Medicine, ³ Pediatrics, ⁴ Pathology and Gynecology and Obstetrics, ⁵ Molecular and Comparative Pathobiology, and ⁶ Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland; ⁷ The University of Texas Southwestern Medical Center, Dallas, Texas; ⁸ Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania; ⁹ Washington University, Pullman, Washington; and ¹⁰ Gynecologic Pathology, Cornell University, New York, New York

Requests for reprints: Linda M. S. Resar, The Johns Hopkins University School of Medicine, Ross Research Building, Room 1025, 720 Rutland Avenue, Baltimore, MD 21205. Phone: 410-614-0712; Fax: 410-955-0185; E-mail: lresar{at}jhmi.edu.

Uterine cancer is the most common cancer of the female genital tract and is the fourth most frequent cause of cancer death in women in the U.S. Despite the high prevalence of uterine cancers, the molecular events that lead to neoplastic transformation in the uterus are poorly understood. Moreover, there are limited mouse models to study these malignancies. We generated transgenic mice with high-mobility group A1 gene (HMGA1a) expression targeted to uterine tissue and all female mice developed tumors by 9 months of age. Histopathologically, the tumors resemble human uterine adenosarcoma and are transplantable. To determine whether these findings are relevant to human disease, we evaluated primary human uterine neoplasms and found that HMGA1a mRNA and protein levels are increased in most high-grade neoplasms but not in normal uterine tissue, benign tumors, or most low-grade neoplasms. We also found that HMGA1a up-regulates cyclooxygenase 2 (COX-2) expression in transgenic tumors. Moreover, both HMGA1a and COX-2 expression are up-regulated in high-grade human leiomyosarcomas. Using chromatin immunoprecipitation, HMGA1a binds directly to the COX-2 promoter in human uterine cancer cells in vivo and activates its expression in transfection experiments. We also show that blocking either HMGA1a or COX-2 in high-grade human uterine cancer cells blocks anchorage-independent cell growth in methylcellulose. These findings show that HMGA1a functions as an oncogene when overexpressed in the uterus and contributes to the pathogenesis of human uterine cancer by activating COX-2 expression. Although a larger study is needed to confirm these results, HMGA1a may be a useful marker for aggressive human uterine cancers. [Cancer Res 2007;67(9):3998–4004]

This article has been cited by other articles:

				J. Hillion, L. J. Wood, M. Mukherjee, R. Bhattacharya, F. Di Cello, J. Kowalski, O. Elbahloul, J. Segal, J. Poirier, C. M. Rudin, et al. Upregulation of MMP-2 by HMGA1 Promotes Transformation in Undifferentiated, Large-Cell Lung Cancer Mol. Cancer Res., November 1, 2009; 7(11): 1803 - 1812. [Abstract] [Full Text] [PDF]

				L. Mao, K. J. Wertzler, S. C. Maloney, Z. Wang, N. S. Magnuson, and R. Reeves HMGA1 Levels Influence Mitochondrial Function and Mitochondrial DNA Repair Efficiency Mol. Cell. Biol., October 15, 2009; 29(20): 5426 - 5440. [Abstract] [Full Text] [PDF]

				J. Hillion, S. Dhara, T. F. Sumter, M. Mukherjee, F. Di Cello, A. Belton, J. Turkson, S. Jaganathan, L. Cheng, Z. Ye, et al. The High-Mobility Group A1a/Signal Transducer and Activator of Transcription-3 Axis: An Achilles Heel for Hematopoietic Malignancies? Cancer Res., December 15, 2008; 68(24): 10121 - 10127. [Abstract] [Full Text] [PDF]

				F. Di Cello, J. Hillion, J. Kowalski, B. M. Ronnett, A. Aderinto, D. L. Huso, and L. M.S. Resar Cyclooxygenase inhibitors block uterine tumorigenesis in HMGA1a transgenic mice and human xenografts Mol. Cancer Ther., July 1, 2008; 7(7): 2090 - 2095. [Abstract] [Full Text] [PDF]

				F. Di Cello, J. Hillion, A. Hristov, L. J. Wood, M. Mukherjee, A. Schuldenfrei, J. Kowalski, R. Bhattacharya, R. Ashfaq, and L. M.S. Resar HMGA2 Participates in Transformation in Human Lung Cancer Mol. Cancer Res., May 1, 2008; 6(5): 743 - 750. [Abstract] [Full Text] [PDF]